鱼跃医疗(002223.SZ)拟与蚂蚁集团等发起成立重庆蚂蚁消费金融公司
鱼跃医疗(002223.SZ)公布,拟与蚂蚁集团、千方科技(002373.SZ)、国泰世华银行(中国)、宁德时代(300750.SZ)、南洋商业银行及中国华融(02799.HK)共同出资80亿元人民币在重庆市设立重庆蚂蚁消费金融有限公司(「消金公司」)。
公司於8月21日与上述共同投资合作方签署交易文件,拟以自有资金出资3.99亿元人民币,占消金公司注册资本的4.99%。消金公司成立以後开展消费金融相关业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.